Company Analysis

COMPASS Pathways Plc American Depository Shares (CMPS)

Nasdaq: CMPS · Pharmaceutical Preparations · Chesire, GB · filing with the SEC since 2020
Grade4.7
◀ Past 4.9● Present 3.2▶ Future 5.7
6 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to COMPASS Pathways Plc American Depository Shares’s names, not what it holds today.

Patents granted
1
1 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
3
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'19'20
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
COMPASS Pathways Limited its own name
GB, as the owner printed on each patent
1 granted
2 published
COMPASS Pathways Limited its own name
named as the applicant on its applications, in GB
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 31, 201910,519,175Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their usePharmaceuticalsCOMPASS Pathways Limited
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 22, 20202020/0331939PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEPharmaceuticalsCOMPASS Pathways Limited · patent 10,947,257 granted from it
Jun 25, 20202020/0199161PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEPharmaceuticalsCOMPASS Pathways Limited · patent 11,505,564 granted from it
Apr 25, 20192019/0119310PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USEPharmaceuticalsCOMPASS Pathways Limited · patent 10,519,175 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CMPS · research, not advice